Nasdaq · CIK 0001930313
SBC SBC Medical Group Holdings Inc
Insider trading from SEC Form 4. Last filing Apr 29, 2026. Close $5.42 on Oct 9, 2026, +89% from the 52-week low and 0% from the high.
SBC Medical Group Holdings Inc (SBC) has 3 SEC Form 4 filings on file from 1 insider, the latest filed on Apr 29, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
3 open-market trades have been scored at SBC. The newest: Yoshiyuki Aikawa (Chairman and CEO) sold $1.4M of stock on Apr 28, 2026, filed Apr 29, 2026, scored 50 (moderate). The largest of the 3 shown: Yoshiyuki Aikawa (Chairman and CEO) sold $9.4M on Mar 6, 2026, scored 70 (notable).
SBC closed at $5.42 on Oct 9, 2026, 89% above its 52-week low and at a 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at SBC Medical Group Holdings Inc, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Yoshiyuki Aikawa Chairman and CEO sell | $1.4M 465,000 shares | -1% | - | |
| 50Moderate | Yoshiyuki Aikawa Chairman and CEO sell | $9.4M 3,100,000 shares | -4% | - | |
| 70Notable | Yoshiyuki Aikawa Chairman and CEO sell | $9.4M 4,422,900 shares | -84% | - |
Transactions
Every row filed, 5 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Yoshiyuki Aikawa Chairman and CEO | SOpen-market sale Common Stock | -465,000 | $3.02 | $1.4M | 78,839,460 | Apr 29, 2026 |
| Apr 21, 2026 | Yoshiyuki Aikawa Chairman and CEO | SOpen-market sale Common Stock | -3,100,000 | $3.02 | $9.4M | 79,304,460 | Apr 23, 2026 |
| Mar 6, 2026 | Yoshiyuki Aikawa Chairman and CEO | SOpen-market sale Common Stockindirect: By Aikawa Equity Management Co., Ltd. | -4,422,900 | $2.12 | $9.4M | 861,600 | Mar 10, 2026 |
| Mar 6, 2026 | Yoshiyuki Aikawa Chairman and CEO | JOther Put Options (Right to Sell)derivativeindirect: By Aikawa Equity Management Co., Ltd. | -44,229 | - | - | 44,229 | Mar 10, 2026 |
| Mar 6, 2026 | Yoshiyuki Aikawa Chairman and CEO | JOther Call Options (Right to Buy)derivativeindirect: By Aikawa Equity Management Co., Ltd. | +44,229 | - | - | 44,229 | Mar 10, 2026 |
Questions about SBC
Answered from the filings on this page, as of the latest one.
Are insiders buying SBC?
No. In the last 90 days no insider at SBC Medical Group Holdings Inc bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade SBC on the open market?
Yoshiyuki Aikawa (Chairman and CEO) sold $1.4M of SBC on Apr 28, 2026 and filed the Form 4 on Apr 29, 2026. InsiderTell scored 50 (moderate).
How many insiders file Form 4 at SBC Medical Group Holdings Inc?
1 person has filed a Form 4 at SBC Medical Group Holdings Inc, among them Yoshiyuki Aikawa (Chairman and CEO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.